ATE246491T1 - Impfstoffzusammensetzung auf basis von partikeln - Google Patents

Impfstoffzusammensetzung auf basis von partikeln

Info

Publication number
ATE246491T1
ATE246491T1 AT00912780T AT00912780T ATE246491T1 AT E246491 T1 ATE246491 T1 AT E246491T1 AT 00912780 T AT00912780 T AT 00912780T AT 00912780 T AT00912780 T AT 00912780T AT E246491 T1 ATE246491 T1 AT E246491T1
Authority
AT
Austria
Prior art keywords
particle
vaccine composition
based vaccine
composition
immunostimulant
Prior art date
Application number
AT00912780T
Other languages
English (en)
Inventor
Hazire Oya Alpar
Ethel Diane Williamson
Leslie William James Baillie
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Defence filed Critical Secr Defence
Application granted granted Critical
Publication of ATE246491T1 publication Critical patent/ATE246491T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00912780T 1999-03-24 2000-03-23 Impfstoffzusammensetzung auf basis von partikeln ATE246491T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9906695.3A GB9906695D0 (en) 1999-03-24 1999-03-24 Vaccine composition
PCT/GB2000/001108 WO2000056282A1 (en) 1999-03-24 2000-03-23 Particle based vaccine composition

Publications (1)

Publication Number Publication Date
ATE246491T1 true ATE246491T1 (de) 2003-08-15

Family

ID=10850217

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00912780T ATE246491T1 (de) 1999-03-24 2000-03-23 Impfstoffzusammensetzung auf basis von partikeln

Country Status (10)

Country Link
EP (1) EP1162945B1 (de)
JP (1) JP2002539237A (de)
AT (1) ATE246491T1 (de)
AU (1) AU765208C (de)
CA (1) CA2366613A1 (de)
DE (1) DE60004334T2 (de)
ES (1) ES2203436T3 (de)
GB (1) GB9906695D0 (de)
NZ (1) NZ514322A (de)
WO (1) WO2000056282A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AU2001280934A1 (en) * 2000-07-28 2002-02-13 Alliance Pharmaceutical Corp. Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
JP4679822B2 (ja) * 2002-03-13 2011-05-11 ノバルティス アーゲー 医薬微粒子
US8034378B2 (en) 2002-12-27 2011-10-11 Novartis Vaccines And Diagnostics, Inc Immunogenic compositions containing phospholipid
US8080642B2 (en) 2003-05-16 2011-12-20 Vical Incorporated Severe acute respiratory syndrome DNA compositions and methods of use
SE527505C2 (sv) * 2003-06-10 2006-03-28 Anna Imberg Komposita material och partiklar
GB0519871D0 (en) 2005-09-30 2005-11-09 Secr Defence Immunogenic agents
JP4510842B2 (ja) * 2007-03-26 2010-07-28 キヤノン株式会社 ポリヒドロキシアルカノエート被覆リポソーム
GB0721937D0 (en) 2007-11-08 2007-12-19 Secr Defence Rodenticide
GB0900455D0 (en) 2009-01-13 2009-02-11 Secr Defence Vaccine
WO2019191293A1 (en) * 2018-03-27 2019-10-03 Locus Ip Company, Llc Materials and methods for diagnosing, preventing and/or treating infections by pathogenic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2046092B (en) * 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
DE69332031T2 (de) * 1993-01-08 2002-12-19 Csl Ltd Impfstoffpräparate
DE19603649A1 (de) * 1996-02-01 1997-08-07 Werner Lubitz Rekombinante Expression von S-Layer-Proteinen

Also Published As

Publication number Publication date
JP2002539237A (ja) 2002-11-19
EP1162945A1 (de) 2001-12-19
DE60004334D1 (de) 2003-09-11
AU765208B2 (en) 2003-09-11
CA2366613A1 (en) 2000-09-28
DE60004334T2 (de) 2004-04-22
NZ514322A (en) 2003-03-28
AU3442700A (en) 2000-10-09
WO2000056282A1 (en) 2000-09-28
AU765208C (en) 2004-04-22
ES2203436T3 (es) 2004-04-16
GB9906695D0 (en) 1999-05-19
EP1162945B1 (de) 2003-08-06

Similar Documents

Publication Publication Date Title
ATE246491T1 (de) Impfstoffzusammensetzung auf basis von partikeln
ATE231184T1 (de) Impfstoffe gegen die pest
NZ504894A (en) Crystalline vaccine and adjuvant compositions jointly and separately administered to animals using a transdermal or transmucosally delivery technique
NZ218825A (en) Use of low dosages of interferon as adjuvants for vaccines
DE60011589D1 (de) Hochwirksame dihydroergotaminhaltige arzneizusammensetzungen
BR0108402A (pt) Análogos de nucleosìdeo com base monocìclica carboxamidina modificado
DE69637961D1 (de) Verabreichung von biologisch aktiven polypeptiden
CY1109489T1 (el) Συσκευη χορηγησης φαρμακου
DE69225135D1 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
ATE298562T1 (de) Hydrogelpartikel formulierungen
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
IL173481A0 (en) Polysaccharide double-layer microcapsules as carriers for biologically active substance oral administration
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
Moni et al. Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations
ATE515258T1 (de) Mukosales verabreichungssytem
WO1999053950A3 (en) Live vaccines and methods of treatment therewith
ATE334658T1 (de) Arzneimittel zur verabreichung an schleimhäute
OA09672A (en) Use of il-4 to enhance immune response to infectious antigenic challenges
EP1131338A4 (de) Methode für die herstellung von gereinigtem invasinprotein und seine anwendung
Alexander et al. Adjuvants and their modes of action
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
Lofthouse et al. The application of biodegradable collagen minipellets as vaccine delivery vehicles in mice and sheep
AR009866A1 (es) Formulacion inmunopotenciadora para uso vacunal
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties